COVID-19 and coagulative axis: review of emerging aspects in a novel disease

Submitted: April 9, 2020
Accepted: May 12, 2020
Published: May 19, 2020
Abstract Views: 5162
PDF: 2708
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is commonly complicated with coagulopathy and that disseminated intravascular coagulation is present in the majority of deceased patients. Particularly, conventional coagulation parameters appear to be significantly altered in patients with poor prognosis. A wide-ranging cross- talk between coagulative haemostasis and inflammation, as well as the activation of coagulation cascade during viral infections, are well established. Another important evidence which may explain coagulation disorders in COVID-19 is the increase of thrombus formation under conditions of hypoxia. Despite the exact pathophysiological mechanism of coronavirus-induced thromboembolism needs to be further investigated, this finding suggests that it is good practice to assess the risk of thrombosis in COVID-19 patients to improve the clinical management in terms of anticoagulation therapy. Anticoagulants, mainly low-molecular-weight heparin (LMWH), should be tailored in patients meeting sepsis induced coagulopathy (SIC) criteria or with markedly elevated D-dimer. In this context, further studies are needed to optimise the decision making in therapeutic approach.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Boccia, Matilde, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D’Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, and Fabio Perrotta. 2020. “COVID-19 and Coagulative Axis: Review of Emerging Aspects in a Novel Disease”. Monaldi Archives for Chest Disease 90 (2). https://doi.org/10.4081/monaldi.2020.1300.